Beijing PolySeq Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures
March 19, 2023
Share
Beijing PolySeq Technology Co., Ltd. announced a placement of common shares for gross proceeds of CNY 40,000,000 on March 20, 2023. The transaction will include participation from new investors, Guangzhou Wondfo Biotech Co.,Ltd for 6.25% stake and Guangzhou Zhongfu Yide Equity InvesGuangzhou Sanmei Investment Management Center (Limited Partnership)tment Partnership Enterprise (L.P.), a fund managed by, Guangzhou Sanmei Investment Management Center (Limited Partnership) for 2.08% stake.
GUANGZHOU WONDFO BIOTECH CO., LTD. is a China-based company principally engaged in research, manufacture and sales of point-of-care testing (POCT) reagents, POCT instrument and related products. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The Company's products are used in POCT, clinical test, field test and personal health management, among others.
Beijing PolySeq Technology Co., Ltd. announced that it expects to receive CNY 40 million in funding from Guangzhou Wondfo Biotech Co.,Ltd, Guangzhou Sanmei Investment Management Center (Limited Partnership), Shangshi Capital, IDG Capital Partners Co., Ltd., Tsinghua Innovation Ventures
GUANGZHOU WONDFO BIOTECH CO.,LTD 
